Quick Dispatch:
Your case report aspiration glp-1 receptor agonist anesthesia 2023 New therapeutic agents for type 2 diabetes: anaesthetic considerations. A narrative review orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your case report aspiration glp-1 receptor agonist anesthesia 2023 New therapeutic agents for type 2 diabetes: anaesthetic considerations. A narrative review ships.
Need Help?
Questions about case report aspiration glp-1 receptor agonist anesthesia 2023 New therapeutic agents for type 2 diabetes: anaesthetic considerations. A narrative review, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for case report aspiration glp-1 receptor agonist anesthesia 2023 New therapeutic agents for type 2 diabetes: anaesthetic considerations. A narrative review in your area.
American Society for Gastrointestinal Endoscopy position statement on periendoscopic management of patients on glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors
20.13
Peri-Procedural Safety of GLP-1 Receptor Agonists in Elective Endoscopy: A Multicenter Retrospective Cohort Study
22.76
GLP-1 drugs and aspiration risk
20.72
Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists: Risk of Aspiration during Anesthesia
26.81
🔴 GLP-1 RAs and Anesthesia: 2025 Consensus Update: Patients on GLP-1 receptor agonists (e.g., semaglutide, tirzepatide, dulaglutide) can continue their medications before anesthesia if asymptomatic, with extended fasting to reduce aspiration risk
23.79
Updated guidance for patients using GLP-1/GIP receptor agonists
22.34
Novo Nordisk promotes new GLP-1 receptor agonist to fight diabetes, obesity < Pharma < Article
28.16
